Post-Market Bioequivalence of Generic Drug Products

Inactive
Notice ID:Amendment75F40123R00023

This posting serves as an amendment to Solicitation 75F40124R00023. Q&A were revised, see attached. Proposals are due 10EST 02/29/2024

Department/Ind.Agency Subtier Office
HEALTH AND HUMAN SERVICES, DEPARTMENT OF FOOD AND DRUG ADMINISTRATION FDA CENTER FOR DRUG EVALUATION AND RESEARCH
NAICS 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
  PSC   SCIENTIFIC DATA STUDIES


Data sourced from SAM.gov. View Official Posting »

Notification